By selecting the Yes option, leaving Amgen.com.sg option you understand that you are leaving the corporate page of Amgen Singapore and that you will be redirected to another Internet site belonging to third parties, for whose content or opinions Amgen Singapore is not responsible and makes no representations regarding such content or its accuracy. By selecting this option and accessing linked third party sites, you understand that you do so at your own risk.
The website to which you will be redirected may be designed exclusively for residents of a particular country or countries, as advertised on that website. As a consequence, the website to which you will be directed may contain information on pharmaceutical products or indications that are not approved in Singapore. If You reside in a country other than the one to which such website is directed, please contact your local Amgen affiliate for the correct information on products in your country of residence.
Inflammation is part of the body's defense mechanism. It is the process by which the immune system recognizes and removes harmful and foreign stimuli and begins the healing process1.
Under certain conditions, this inflammation can turn against our body and enter an abnormal phase for several weeks, several years or even a lifetime. This is then referred to as chronic inflammation. Inflammatory diseases can affect most organs and tissues of the human body including the digestive system, nervous system, epidermis and joints2.
People who suffer from it often experience suffering and may experience significant discomfort and restrictions in their daily life. The impact on the social, family and professional lives of patients and those around them is significant, especially when some of these diseases coexist. The psychological impact is also significant and adds to the burden of recurring physical suffering .
Amgen has been committed to fighting chronic inflammatory diseases and better supporting healthcare professionals and patients. Our approach involves the search for new therapeutic solutions, the continued development of biosimilars, and supporting initiatives aimed at improving diagnosis, the care pathway and patient support.